Opinion · 28 Feb 2025
Review articlePublished 2018
Immunomodulators in Autoimmunity and Viral Infections
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immunologically-based therapies are steadily moving from the laboratory to clinical practice. In that regard, the elevated levels of “immunocytokine” gene expression, including, tumor necrosis factor-α, various interleukins, cytotoxic T-cell antigen-4, B-cell activating factor, and others, are characteristic of autoimmune diseases, such as rheumatoid arthritis, inflammatory bowel diseases, psoriatic arthritis and system lupus erythematosus and, some cancers as well. Treatment of these autoimmune diseases with first-line Immunologically-based therapies can ameliorate the pathology associated with autoimmunity and cancer and, can also inhibit transplant rejection. Importantly, drugs containing immunomodulatory activity are now also known to have significant and effective anti-viral activity which may result from their role in reducing the impact of “immunocytokines” on viral infectivity and disease progression. Although vaccine development continues to alter the landscape of virally-associated diseases, immunomodulation has become a useful paradigm for reducing the pathology associated with viral infection(s) going forward.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 28 Jun 2024
Immunomodulators in Autoimmune Diseases: Impact, Treatment and Applications
Conference abstract · 24 May 2021
Light/Dark Rhythm of the Pineal Immunomodulating, Hormone Melatonin in Autoimmune Diseases and its Relation to Lymphocyte-to-Monocyte Ratio.
Research article · 8 Nov 2019
Light/Dark Rhythm of the Pineal Immunomodulating Hormone Melatonin in Autoimmune Diseases and its Relation to Lymphocyte-to-Monocyte Ratio
Editorial · 31 Jan 2025
Harnessing Immunomodulation: Strategies to Enhance Immune Responses in Autoimmunity and Cancer
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Charles J Malemud”

